0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bone Graft Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-38H16626
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bone Graft Biologics Market Research Report 2024
BUY CHAPTERS

Global Bone Graft Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-38H16626
Report
November 2025
Pages:175
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bone Graft Biologics Market

The global Bone Graft Biologics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Bone Graft Biologics leading manufacturers including Medtronic, Depuy Synthes, Stryker Corporation, Zimmer Biomet, Orthofix International, Globus Medical, Exactech, Wright Medical Technology, X-Spine, Nutech, etc., dominate supply; the top five capture approximately % of global revenue, with Medtronic leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bone Graft Biologics market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Bone Graft Biologics Market Report

Report Metric Details
Report Name Bone Graft Biologics Market
Segment by Type
  • Demineralized Bone Matrix (DBM) Fiber
  • Demineralized Bone Matrix (DBM) Sponge
  • Others
Segment by Application
  • Hospital
  • Orthopedic Specialist Clinic
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Depuy Synthes, Stryker Corporation, Zimmer Biomet, Orthofix International, Globus Medical, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex, ATEC Spine, Kuros Biosciences, ChoiceSpine, MTF Biologics, SeaSpine, Straumann, Xtant Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Bone Graft Biologics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Bone Graft Biologics Market report?

Ans: The main players in the Bone Graft Biologics Market are Medtronic, Depuy Synthes, Stryker Corporation, Zimmer Biomet, Orthofix International, Globus Medical, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex, ATEC Spine, Kuros Biosciences, ChoiceSpine, MTF Biologics, SeaSpine, Straumann, Xtant Medical

What are the Application segmentation covered in the Bone Graft Biologics Market report?

Ans: The Applications covered in the Bone Graft Biologics Market report are Hospital, Orthopedic Specialist Clinic

What are the Type segmentation covered in the Bone Graft Biologics Market report?

Ans: The Types covered in the Bone Graft Biologics Market report are Demineralized Bone Matrix (DBM) Fiber, Demineralized Bone Matrix (DBM) Sponge, Others

1 Study Coverage
1.1 Introduction to Bone Graft Biologics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bone Graft Biologics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Demineralized Bone Matrix (DBM) Fiber
1.2.3 Demineralized Bone Matrix (DBM) Sponge
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Bone Graft Biologics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Orthopedic Specialist Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bone Graft Biologics Revenue Estimates and Forecasts 2020-2031
2.2 Global Bone Graft Biologics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bone Graft Biologics Sales Estimates and Forecasts 2020-2031
2.4 Global Bone Graft Biologics Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Bone Graft Biologics Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Bone Graft Biologics Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Demineralized Bone Matrix (DBM) Fiber Market Size by Manufacturers
3.5.2 Demineralized Bone Matrix (DBM) Sponge Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Bone Graft Biologics Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bone Graft Biologics Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Bone Graft Biologics Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bone Graft Biologics Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Bone Graft Biologics Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Bone Graft Biologics Sales and Revenue by Type (2020-2031)
6.4 North America Bone Graft Biologics Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bone Graft Biologics Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Bone Graft Biologics Sales and Revenue by Type (2020-2031)
7.4 Europe Bone Graft Biologics Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bone Graft Biologics Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Bone Graft Biologics Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Bone Graft Biologics Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Bone Graft Biologics Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Bone Graft Biologics Sales and Revenue by Type (2020-2031)
9.4 Central and South America Bone Graft Biologics Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bone Graft Biologics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Bone Graft Biologics Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Bone Graft Biologics Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bone Graft Biologics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Bone Graft Biologics Product Models, Descriptions and Specifications
11.1.4 Medtronic Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Bone Graft Biologics Sales by Product in 2024
11.1.6 Medtronic Bone Graft Biologics Sales by Application in 2024
11.1.7 Medtronic Bone Graft Biologics Sales by Geographic Area in 2024
11.1.8 Medtronic Bone Graft Biologics SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Depuy Synthes
11.2.1 Depuy Synthes Corporation Information
11.2.2 Depuy Synthes Business Overview
11.2.3 Depuy Synthes Bone Graft Biologics Product Models, Descriptions and Specifications
11.2.4 Depuy Synthes Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Depuy Synthes Bone Graft Biologics Sales by Product in 2024
11.2.6 Depuy Synthes Bone Graft Biologics Sales by Application in 2024
11.2.7 Depuy Synthes Bone Graft Biologics Sales by Geographic Area in 2024
11.2.8 Depuy Synthes Bone Graft Biologics SWOT Analysis
11.2.9 Depuy Synthes Recent Developments
11.3 Stryker Corporation
11.3.1 Stryker Corporation Corporation Information
11.3.2 Stryker Corporation Business Overview
11.3.3 Stryker Corporation Bone Graft Biologics Product Models, Descriptions and Specifications
11.3.4 Stryker Corporation Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Stryker Corporation Bone Graft Biologics Sales by Product in 2024
11.3.6 Stryker Corporation Bone Graft Biologics Sales by Application in 2024
11.3.7 Stryker Corporation Bone Graft Biologics Sales by Geographic Area in 2024
11.3.8 Stryker Corporation Bone Graft Biologics SWOT Analysis
11.3.9 Stryker Corporation Recent Developments
11.4 Zimmer Biomet
11.4.1 Zimmer Biomet Corporation Information
11.4.2 Zimmer Biomet Business Overview
11.4.3 Zimmer Biomet Bone Graft Biologics Product Models, Descriptions and Specifications
11.4.4 Zimmer Biomet Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Zimmer Biomet Bone Graft Biologics Sales by Product in 2024
11.4.6 Zimmer Biomet Bone Graft Biologics Sales by Application in 2024
11.4.7 Zimmer Biomet Bone Graft Biologics Sales by Geographic Area in 2024
11.4.8 Zimmer Biomet Bone Graft Biologics SWOT Analysis
11.4.9 Zimmer Biomet Recent Developments
11.5 Orthofix International
11.5.1 Orthofix International Corporation Information
11.5.2 Orthofix International Business Overview
11.5.3 Orthofix International Bone Graft Biologics Product Models, Descriptions and Specifications
11.5.4 Orthofix International Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Orthofix International Bone Graft Biologics Sales by Product in 2024
11.5.6 Orthofix International Bone Graft Biologics Sales by Application in 2024
11.5.7 Orthofix International Bone Graft Biologics Sales by Geographic Area in 2024
11.5.8 Orthofix International Bone Graft Biologics SWOT Analysis
11.5.9 Orthofix International Recent Developments
11.6 Globus Medical
11.6.1 Globus Medical Corporation Information
11.6.2 Globus Medical Business Overview
11.6.3 Globus Medical Bone Graft Biologics Product Models, Descriptions and Specifications
11.6.4 Globus Medical Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Globus Medical Recent Developments
11.7 Exactech
11.7.1 Exactech Corporation Information
11.7.2 Exactech Business Overview
11.7.3 Exactech Bone Graft Biologics Product Models, Descriptions and Specifications
11.7.4 Exactech Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Exactech Recent Developments
11.8 Wright Medical Technology
11.8.1 Wright Medical Technology Corporation Information
11.8.2 Wright Medical Technology Business Overview
11.8.3 Wright Medical Technology Bone Graft Biologics Product Models, Descriptions and Specifications
11.8.4 Wright Medical Technology Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Wright Medical Technology Recent Developments
11.9 X-Spine
11.9.1 X-Spine Corporation Information
11.9.2 X-Spine Business Overview
11.9.3 X-Spine Bone Graft Biologics Product Models, Descriptions and Specifications
11.9.4 X-Spine Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 X-Spine Recent Developments
11.10 Nutech
11.10.1 Nutech Corporation Information
11.10.2 Nutech Business Overview
11.10.3 Nutech Bone Graft Biologics Product Models, Descriptions and Specifications
11.10.4 Nutech Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Nutech Recent Developments
11.11 Arthrex
11.11.1 Arthrex Corporation Information
11.11.2 Arthrex Business Overview
11.11.3 Arthrex Bone Graft Biologics Product Models, Descriptions and Specifications
11.11.4 Arthrex Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Arthrex Recent Developments
11.12 ATEC Spine
11.12.1 ATEC Spine Corporation Information
11.12.2 ATEC Spine Business Overview
11.12.3 ATEC Spine Bone Graft Biologics Product Models, Descriptions and Specifications
11.12.4 ATEC Spine Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 ATEC Spine Recent Developments
11.13 Kuros Biosciences
11.13.1 Kuros Biosciences Corporation Information
11.13.2 Kuros Biosciences Business Overview
11.13.3 Kuros Biosciences Bone Graft Biologics Product Models, Descriptions and Specifications
11.13.4 Kuros Biosciences Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Kuros Biosciences Recent Developments
11.14 ChoiceSpine
11.14.1 ChoiceSpine Corporation Information
11.14.2 ChoiceSpine Business Overview
11.14.3 ChoiceSpine Bone Graft Biologics Product Models, Descriptions and Specifications
11.14.4 ChoiceSpine Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 ChoiceSpine Recent Developments
11.15 MTF Biologics
11.15.1 MTF Biologics Corporation Information
11.15.2 MTF Biologics Business Overview
11.15.3 MTF Biologics Bone Graft Biologics Product Models, Descriptions and Specifications
11.15.4 MTF Biologics Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 MTF Biologics Recent Developments
11.16 SeaSpine
11.16.1 SeaSpine Corporation Information
11.16.2 SeaSpine Business Overview
11.16.3 SeaSpine Bone Graft Biologics Product Models, Descriptions and Specifications
11.16.4 SeaSpine Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 SeaSpine Recent Developments
11.17 Straumann
11.17.1 Straumann Corporation Information
11.17.2 Straumann Business Overview
11.17.3 Straumann Bone Graft Biologics Product Models, Descriptions and Specifications
11.17.4 Straumann Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Straumann Recent Developments
11.18 Xtant Medical
11.18.1 Xtant Medical Corporation Information
11.18.2 Xtant Medical Business Overview
11.18.3 Xtant Medical Bone Graft Biologics Product Models, Descriptions and Specifications
11.18.4 Xtant Medical Bone Graft Biologics Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Xtant Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Bone Graft Biologics Industry Chain
12.2 Bone Graft Biologics Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Bone Graft Biologics Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Bone Graft Biologics Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bone Graft Biologics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bone Graft Biologics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Bone Graft Biologics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Bone Graft Biologics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Bone Graft Biologics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Bone Graft Biologics Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Bone Graft Biologics Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Bone Graft Biologics Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Bone Graft Biologics Sales by Region (2020-2025) & (K Units)
 Table 8. Global Bone Graft Biologics Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Bone Graft Biologics Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Bone Graft Biologics Sales Share by Manufacturers (2020-2025)
 Table 12. Global Bone Graft Biologics Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Bone Graft Biologics Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Bone Graft Biologics by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bone Graft Biologics as of 2024)
 Table 16. Global Bone Graft Biologics Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Bone Graft Biologics Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Bone Graft Biologics Manufacturing Base and Headquarters
 Table 19. Global Bone Graft Biologics Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Bone Graft Biologics Sales by Type (2020-2025) & (K Units)
 Table 23. Global Bone Graft Biologics Sales by Type (2026-2031) & (K Units)
 Table 24. Global Bone Graft Biologics Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Bone Graft Biologics Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Bone Graft Biologics ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Bone Graft Biologics Sales by Application (2020-2025) & (K Units)
 Table 29. Global Bone Graft Biologics Sales by Application (2026-2031) & (K Units)
 Table 30. Bone Graft Biologics High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Bone Graft Biologics Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Bone Graft Biologics Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Bone Graft Biologics ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Bone Graft Biologics Growth Accelerators and Market Barriers
 Table 37. North America Bone Graft Biologics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Bone Graft Biologics Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Bone Graft Biologics Growth Accelerators and Market Barriers
 Table 40. Europe Bone Graft Biologics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Bone Graft Biologics Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Bone Graft Biologics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Bone Graft Biologics Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Bone Graft Biologics Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Bone Graft Biologics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Bone Graft Biologics Investment Opportunities and Key Challenges
 Table 47. Central and South America Bone Graft Biologics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Bone Graft Biologics Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Bone Graft Biologics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Medtronic Corporation Information
 Table 51. Medtronic Description and Major Businesses
 Table 52. Medtronic Product Models, Descriptions and Specifications
 Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Medtronic Sales Value Proportion by Product in 2024
 Table 55. Medtronic Sales Value Proportion by Application in 2024
 Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 57. Medtronic Bone Graft Biologics SWOT Analysis
 Table 58. Medtronic Recent Developments
 Table 59. Depuy Synthes Corporation Information
 Table 60. Depuy Synthes Description and Major Businesses
 Table 61. Depuy Synthes Product Models, Descriptions and Specifications
 Table 62. Depuy Synthes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Depuy Synthes Sales Value Proportion by Product in 2024
 Table 64. Depuy Synthes Sales Value Proportion by Application in 2024
 Table 65. Depuy Synthes Sales Value Proportion by Geographic Area in 2024
 Table 66. Depuy Synthes Bone Graft Biologics SWOT Analysis
 Table 67. Depuy Synthes Recent Developments
 Table 68. Stryker Corporation Corporation Information
 Table 69. Stryker Corporation Description and Major Businesses
 Table 70. Stryker Corporation Product Models, Descriptions and Specifications
 Table 71. Stryker Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Stryker Corporation Sales Value Proportion by Product in 2024
 Table 73. Stryker Corporation Sales Value Proportion by Application in 2024
 Table 74. Stryker Corporation Sales Value Proportion by Geographic Area in 2024
 Table 75. Stryker Corporation Bone Graft Biologics SWOT Analysis
 Table 76. Stryker Corporation Recent Developments
 Table 77. Zimmer Biomet Corporation Information
 Table 78. Zimmer Biomet Description and Major Businesses
 Table 79. Zimmer Biomet Product Models, Descriptions and Specifications
 Table 80. Zimmer Biomet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Zimmer Biomet Sales Value Proportion by Product in 2024
 Table 82. Zimmer Biomet Sales Value Proportion by Application in 2024
 Table 83. Zimmer Biomet Sales Value Proportion by Geographic Area in 2024
 Table 84. Zimmer Biomet Bone Graft Biologics SWOT Analysis
 Table 85. Zimmer Biomet Recent Developments
 Table 86. Orthofix International Corporation Information
 Table 87. Orthofix International Description and Major Businesses
 Table 88. Orthofix International Product Models, Descriptions and Specifications
 Table 89. Orthofix International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Orthofix International Sales Value Proportion by Product in 2024
 Table 91. Orthofix International Sales Value Proportion by Application in 2024
 Table 92. Orthofix International Sales Value Proportion by Geographic Area in 2024
 Table 93. Orthofix International Bone Graft Biologics SWOT Analysis
 Table 94. Orthofix International Recent Developments
 Table 95. Globus Medical Corporation Information
 Table 96. Globus Medical Description and Major Businesses
 Table 97. Globus Medical Product Models, Descriptions and Specifications
 Table 98. Globus Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Globus Medical Recent Developments
 Table 100. Exactech Corporation Information
 Table 101. Exactech Description and Major Businesses
 Table 102. Exactech Product Models, Descriptions and Specifications
 Table 103. Exactech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Exactech Recent Developments
 Table 105. Wright Medical Technology Corporation Information
 Table 106. Wright Medical Technology Description and Major Businesses
 Table 107. Wright Medical Technology Product Models, Descriptions and Specifications
 Table 108. Wright Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Wright Medical Technology Recent Developments
 Table 110. X-Spine Corporation Information
 Table 111. X-Spine Description and Major Businesses
 Table 112. X-Spine Product Models, Descriptions and Specifications
 Table 113. X-Spine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. X-Spine Recent Developments
 Table 115. Nutech Corporation Information
 Table 116. Nutech Description and Major Businesses
 Table 117. Nutech Product Models, Descriptions and Specifications
 Table 118. Nutech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Nutech Recent Developments
 Table 120. Arthrex Corporation Information
 Table 121. Arthrex Description and Major Businesses
 Table 122. Arthrex Product Models, Descriptions and Specifications
 Table 123. Arthrex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Arthrex Recent Developments
 Table 125. ATEC Spine Corporation Information
 Table 126. ATEC Spine Description and Major Businesses
 Table 127. ATEC Spine Product Models, Descriptions and Specifications
 Table 128. ATEC Spine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. ATEC Spine Recent Developments
 Table 130. Kuros Biosciences Corporation Information
 Table 131. Kuros Biosciences Description and Major Businesses
 Table 132. Kuros Biosciences Product Models, Descriptions and Specifications
 Table 133. Kuros Biosciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Kuros Biosciences Recent Developments
 Table 135. ChoiceSpine Corporation Information
 Table 136. ChoiceSpine Description and Major Businesses
 Table 137. ChoiceSpine Product Models, Descriptions and Specifications
 Table 138. ChoiceSpine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. ChoiceSpine Recent Developments
 Table 140. MTF Biologics Corporation Information
 Table 141. MTF Biologics Description and Major Businesses
 Table 142. MTF Biologics Product Models, Descriptions and Specifications
 Table 143. MTF Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. MTF Biologics Recent Developments
 Table 145. SeaSpine Corporation Information
 Table 146. SeaSpine Description and Major Businesses
 Table 147. SeaSpine Product Models, Descriptions and Specifications
 Table 148. SeaSpine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. SeaSpine Recent Developments
 Table 150. Straumann Corporation Information
 Table 151. Straumann Description and Major Businesses
 Table 152. Straumann Product Models, Descriptions and Specifications
 Table 153. Straumann Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. Straumann Recent Developments
 Table 155. Xtant Medical Corporation Information
 Table 156. Xtant Medical Description and Major Businesses
 Table 157. Xtant Medical Product Models, Descriptions and Specifications
 Table 158. Xtant Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 159. Xtant Medical Recent Developments
 Table 160. Key Raw Materials Distribution
 Table 161. Raw Materials Key Suppliers
 Table 162. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 163. Milestones in Production Technology Evolution
 Table 164. Distributors List
 Table 165. Market Trends and Market Evolution
 Table 166. Market Drivers and Opportunities
 Table 167. Market Challenges, Risks, and Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources


List of Figures
 Figure 1. Bone Graft Biologics Product Picture
 Figure 2. Global Bone Graft Biologics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Demineralized Bone Matrix (DBM) Fiber Product Picture
 Figure 4. Demineralized Bone Matrix (DBM) Sponge Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Bone Graft Biologics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Orthopedic Specialist Clinic
 Figure 9. Bone Graft Biologics Report Years Considered
 Figure 10. Global Bone Graft Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Bone Graft Biologics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Bone Graft Biologics Revenue Market Share by Region (2020-2031)
 Figure 14. Global Bone Graft Biologics Sales (2020-2031) & (K Units)
 Figure 15. Global Bone Graft Biologics Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Bone Graft Biologics Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Bone Graft Biologics Sales Volume Market Share in 2024
 Figure 18. Global Bone Graft Biologics Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Demineralized Bone Matrix (DBM) Fiber Revenue Market Share by Manufacturer in 2024
 Figure 21. Demineralized Bone Matrix (DBM) Sponge Revenue Market Share by Manufacturer in 2024
 Figure 22. Others Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Bone Graft Biologics Sales Market Share by Type (2020-2031)
 Figure 24. Global Bone Graft Biologics Revenue Market Share by Type (2020-2031)
 Figure 25. Global Bone Graft Biologics Sales Market Share by Application (2020-2031)
 Figure 26. Global Bone Graft Biologics Revenue Market Share by Application (2020-2031)
 Figure 27. North America Bone Graft Biologics Sales YoY (2020-2031) & (K Units)
 Figure 28. North America Bone Graft Biologics Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Bone Graft Biologics Sales Revenue (US$ Million) in 2024
 Figure 30. North America Bone Graft Biologics Sales Volume (K Units) by Type (2020- 2031)
 Figure 31. North America Bone Graft Biologics Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Bone Graft Biologics Sales Volume (K Units) by Application (2020-2031)
 Figure 33. North America Bone Graft Biologics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Bone Graft Biologics Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe Bone Graft Biologics Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Bone Graft Biologics Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Bone Graft Biologics Sales Volume (K Units) by Type (2020-2031)
 Figure 41. Europe Bone Graft Biologics Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Bone Graft Biologics Sales Volume (K Units) by Application (2020-2031)
 Figure 43. Europe Bone Graft Biologics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 45. France Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Bone Graft Biologics Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific Bone Graft Biologics Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Bone Graft Biologics Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Bone Graft Biologics Sales Volume (K Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Bone Graft Biologics Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Bone Graft Biologics Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Bone Graft Biologics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 60. India Bone Graft Biologics Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Bone Graft Biologics Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America Bone Graft Biologics Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Bone Graft Biologics Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Bone Graft Biologics Sales Volume (K Units) by Type (2021-2031)
 Figure 65. Central and South America Bone Graft Biologics Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Bone Graft Biologics Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Central and South America Bone Graft Biologics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Bone Graft Biologics Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Bone Graft Biologics Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Bone Graft Biologics Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa Bone Graft Biologics Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Bone Graft Biologics Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Bone Graft Biologics Sales Volume (K Units) by Type (2021-2031)
 Figure 74. South America Bone Graft Biologics Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Bone Graft Biologics Sales Volume (K Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Bone Graft Biologics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Bone Graft Biologics Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Bone Graft Biologics Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Bone Graft Biologics Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Bone Graft Biologics Revenue (2020-2025) & (US$ Million)
 Figure 81. Bone Graft Biologics Industry Chain Mapping
 Figure 82. Regional Bone Graft Biologics Manufacturing Base Distribution (%)
 Figure 83. Global Bone Graft Biologics Production Market Share by Region (2020-2031)
 Figure 84. Bone Graft Biologics Production Process
 Figure 85. Regional Bone Graft Biologics Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools